Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **peroxynitrite-driven toxicity pathway** is not a single molecular target but rather a pathological process involving the formation and action of the reactive nitrogen species *peroxynitrite* (ONOO⁻). Peroxynitrite is generated in vivo by the rapid reaction between nitric oxide (NO) and superoxide anion (O₂•−), both produced during inflammation or cellular stress. It is a potent oxidant capable of damaging proteins, lipids, and DNA through direct oxidation or nitration reactions. This leads to disruption of enzyme activities, mitochondrial dysfunction, membrane channel inhibition, lipid peroxidation, DNA strand breaks with activation of poly(ADP-ribose) polymerase (PARP), energetic collapse in cells, apoptosis or necrosis[3][5]. \n\nPeroxynitrite-mediated cytotoxicity has been implicated in various diseases including neurodegeneration (e.g., white matter injury via microglial activation), cardiovascular disorders such as circulatory shock where it contributes to vascular failure and barrier dysfunctions[1][3], drug-induced toxicities from agents like doxorubicin and paraquat that increase its production[5], as well as general inflammatory conditions.\n\nTherapeutic strategies have focused on neutralizing peroxynitrite using decomposition catalysts like FeTMPyP or MnTMPyP—these have shown protective effects in preclinical models—or reducing its precursors via NOS inhibitors or SOD mimetics. However, because NO itself has essential physiological roles—including vasodilation and immune regulation—broad suppression can lead to adverse effects; thus selective targeting remains challenging[8].\n\n**Note:** "Peroxynitrite-driven toxicity pathway" refers to a mechanism/pathway rather than a discrete molecular entity such as an enzyme or receptor. Therefore it should not be considered a canonical therapeutic target but rather describes the downstream consequences of excessive reactive nitrogen species generation. For structured data purposes this entry would be flagged for review due to being mechanistic/pathway-based instead of representing an individual molecule/protein/receptor suitable for direct pharmacological targeting.
Scavenging or decomposing peroxynitrite to prevent oxidative damage\n- Inhibiting precursor radical formation (NO synthase inhibitors; SOD mimetics)\n- Enhancing endogenous antioxidant defenses
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peroxynitrite-driven toxicity pathway.